Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.370 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.370
Bid (Size) 1.310 (200)
Ask (Size) 1.390 (200)
Prev. Close 1.370
Today's Range 1.370 - 1.370
52wk Range 1.100 - 27.63
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Patients Need to Know About Exercising During Cancer Treatment
Via Investor Brand Network
Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer
Via Investor Brand Network

Performance

YTD
-90.3%
-90.3%
1 Month
-11.0%
-11.0%
3 Month
-12.2%
-12.2%
6 Month
-71.5%
-71.5%
1 Year
-94.3%
-94.3%

More News

Read More
Rarest Natural Element Promises to Revolutionize How Cancer is Treated
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells
Via Investor Brand Network
Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy
Via Investor Brand Network
Lung Cancer Screening is Still Woefully Low in the US, Report Shows
Via Investor Brand Network
Topics Death
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
Via Investor Brand Network
Researchers Urge Canadians to Donate Toenails, for Science
Via Investor Brand Network
Researchers Discover Why Cancer Immunotherapy Could Be Failing
Via Investor Brand Network
Lund University Researchers Discover Why Leukemia Cells Evade the Immune System
Via Investor Brand Network
Researchers Find That Common Nutrient Could Supercharge the Immune Cells Fighting Cancer
Via Investor Brand Network
How Patients Can Boost Dietary Nutrient Intake During Cancer Treatment
Via Investor Brand Network
Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present at H.C. Wainwright Global Investment Conference
Via Investor Brand Network
New Study Discovers Unexpected Reason for Resistance to Cancer Immunotherapy
Via Investor Brand Network
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option
Via Investor Brand Network
Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors
Via Investor Brand Network
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Nasdaq Down 1%; Lowe's Posts Upbeat Earnings ↗
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Prices $6 Million Public Offering
Via Investor Brand Network
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 1.370
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 11/21/25 08:00 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 9.82M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.